Mi SciELO
Servicios personalizadosServicios Personalizados
Revista
Articulo
Español (pdf)
Articulo en XML
Referencias del artículo
Traducción automática
Enviar articulo por emailIndicadores
Citado por SciELO 
Accesos
Links relacionados
Citado por Google 
Similares en
SciELO 
Similares en Google
Compartir
Permalink
Revista de la Asociación Española de Especialistas en Medicina del Trabajo
versión On-line ISSN 3020-1160versión impresa ISSN 1132-6255
Resumen
DE LA FUENTE-MARTIN, José Manuel et al. Need for immunological determination of Quantiferon (Interferon-gamma Relase-Assay) for the diagnosis of latent tuberculous infection. Rev Asoc Esp Espec Med Trab [online]. 2022, vol.31, n.3, pp.254-259. Epub 12-Dic-2022. ISSN 3020-1160.
Introduction:
Tuberculosis is a major public health problem, first cause of death in adults infected with a single infectious agent. We will differentiate active tuberculosis disease from latent tuberculosis infection. The biological control of the initial health examination establishes whether the worker is a carrier of LTTI to differentiate him/her from a possible subsequent contagion at work.
Objectives:
General objective to estimate the validity of Mantoux/Booster and Quantiferon as diagnostic tests for LTTI. Specific objective: To define the cases diagnosed as ITL.
Material and Methods:
Collection of data from the clinical-work histories of newly hired personnel, from the Zamora Health Area, years 2018-2021, imported into a database, qualitative/quantitative descriptive study is performed.
Results:
29.1% of the workers studied were tuberculin positive; 10.3% were Quantiferon positive. We diagnosed 159 cases of ITL.
Conclusion:
The most accurate technique to diagnose ITL is the determination of Quantiferon.
Palabras clave : Tuberculosis; Latent Tuberculous Infection; Tuberculin test; Quantiferon.
